Average Co-Inventor Count = 4.34
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Immunogen, Inc. (11 from 255 patents)
2. Debiopharm International, S.a. (1 from 20 patents)
12 patents:
1. 11932701 - Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate
2. 11834498 - Biparatopic FR-alpha antibodies and immunoconjugates
3. 11396543 - Biparatopic FR-α antibodies and immunoconjugates
4. 10556958 - CD37-binding molecules and immunoconjugates thereof
5. 10544230 - Methods of using antibodies to detect folate receptor 1 (FOLR1)
6. 10017578 - Methods of treating cancer in a patient by administering anti-folate-receptor-1 (FOLR1) antibodies
7. 9637547 - Monoclonal antibodies for detection of folate receptor 1
8. 9447189 - CD37-binding molecules and immunoconjugates thereof
9. 9238690 - Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
10. 9233171 - Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate
11. 9125896 - EGFR-binding molecules and immunoconjugates thereof
12. 8790649 - EGFR-binding molecules and immunoconjugates thereof